Reported Earnings • Mar 02
Full year 2025 earnings released: ฿1.11 loss per share (vs ฿1.10 loss in FY 2024) Full year 2025 results: ฿1.11 loss per share (further deteriorated from ฿1.10 loss in FY 2024). Revenue: ฿4.99b (down 19% from FY 2024). Net loss: ฿843.6m (flat on FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance. Annuncio • Feb 27
TCM Corporation Public Company Limited, Annual General Meeting, Apr 29, 2026 TCM Corporation Public Company Limited, Annual General Meeting, Apr 29, 2026, at 14:00 SE Asia Standard Time. Reported Earnings • Nov 15
Third quarter 2025 earnings released: ฿0.76 loss per share (vs ฿0.064 loss in 3Q 2024) Third quarter 2025 results: ฿0.76 loss per share (further deteriorated from ฿0.064 loss in 3Q 2024). Revenue: ฿1.20b (down 19% from 3Q 2024). Net loss: ฿582.9m (loss widened ฿534.4m from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance. New Risk • Oct 10
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ฿312.9m (US$9.57m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 63% per year over the past 5 years. Market cap is less than US$10m (฿312.9m market cap, or US$9.57m). Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change). Buy Or Sell Opportunity • Oct 08
Now 22% undervalued Over the last 90 days, the stock has risen 4.8% to ฿0.44. The fair value is estimated to be ฿0.56, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 17% over the last 3 years. Earnings per share has declined by 121%. Reported Earnings • Aug 16
Second quarter 2025 earnings released: ฿0.27 loss per share (vs ฿0.13 loss in 2Q 2024) Second quarter 2025 results: ฿0.27 loss per share (further deteriorated from ฿0.13 loss in 2Q 2024). Revenue: ฿1.28b (down 13% from 2Q 2024). Net loss: ฿207.4m (loss widened 104% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Jul 03
Now 35% overvalued after recent price rise Over the last 90 days, the stock has risen 9.8% to ฿0.45. The fair value is estimated to be ฿0.33, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 111%. Annuncio • Jun 30
Tcm Corporation Public Company Limited Announces Resignation of Soravis Krairiksh as Independent Director and Chairman of the Audit Committee, Effective June 30, 2025 TCM Corporation Public Company Limited announces Resignation of an Mr. Soravis Krairiksh as Independent Director and Chairman of the Audit Committee. Expire Date is June 30, 2025. Terminate Reason: Resigned from position /the company due to Due to other commitments, the director is unable to fully perform their duties. Buy Or Sell Opportunity • Jun 06
Now 23% overvalued Over the last 90 days, the stock has fallen 8.9% to ฿0.41. The fair value is estimated to be ฿0.33, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 111%. New Risk • Mar 28
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Thai stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10.0% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 40% per year over the past 5 years. Minor Risk Market cap is less than US$100m (฿412.1m market cap, or US$12.1m). New Risk • Mar 06
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ฿335.8m (US$9.96m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10.0% operating cash flow to total debt). Earnings have declined by 40% per year over the past 5 years. Market cap is less than US$10m (฿335.8m market cap, or US$9.96m). Reported Earnings • Mar 04
Full year 2024 earnings released: ฿1.10 loss per share (vs ฿0.066 profit in FY 2023) Full year 2024 results: ฿1.10 loss per share (down from ฿0.066 profit in FY 2023). Revenue: ฿6.14b (down 24% from FY 2023). Net loss: ฿842.4m (down ฿892.7m from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 48 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Mar 03
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 31% to ฿0.49. The fair value is estimated to be ฿0.62, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making. Annuncio • Mar 01
TCM Corporation Public Company Limited, Annual General Meeting, Apr 29, 2025 TCM Corporation Public Company Limited, Annual General Meeting, Apr 29, 2025, at 14:00 SE Asia Standard Time. Location: public company limited, Thailand Buy Or Sell Opportunity • Feb 07
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 30% to ฿0.51. The fair value is estimated to be ฿0.65, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 5.5% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Aug 16
Second quarter 2024 earnings released: ฿0.13 loss per share (vs ฿0.012 profit in 2Q 2023) Second quarter 2024 results: ฿0.13 loss per share (down from ฿0.012 profit in 2Q 2023). Revenue: ฿1.48b (down 31% from 2Q 2023). Net loss: ฿101.6m (down ฿110.9m from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings. Annuncio • Aug 15
TCM Corporation Public Company Limited Approves Board Changes Pursuant to the Meeting of the Board of Directors of TCM Corporation Public Company Limited No. 5/2024, held on 14 August 2024, the Board of Directors acknowledge the resignation of Mr. Isaret Chirathiwat as a Director due to his mission that made him unable to fully perform his duties as a director of the Company, effective from 13 August 2024. In addition, the Board of Directors approved the appointment of Mr. Pira Srivikorn as the director of the Company in place of Mr. Isaret Chirathiwat. The director's term of office shall be based on the remaining term of Mr. Isaret Chirathiwat, effective from 14 August 2024 onwards. New Risk • Aug 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Thai stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Earnings have declined by 21% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Market cap is less than US$100m (฿549.5m market cap, or US$15.6m). Reported Earnings • May 17
First quarter 2024 earnings released: ฿0.10 loss per share (vs ฿0.001 profit in 1Q 2023) First quarter 2024 results: ฿0.10 loss per share (down from ฿0.001 profit in 1Q 2023). Revenue: ฿1.59b (down 21% from 1Q 2023). Net loss: ฿77.7m (down ฿78.8m from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 03
Full year 2023 earnings released: EPS: ฿0.066 (vs ฿0.14 in FY 2022) Full year 2023 results: EPS: ฿0.066 (down from ฿0.14 in FY 2022). Revenue: ฿8.03b (down 12% from FY 2022). Net income: ฿50.3m (down 53% from FY 2022). Profit margin: 0.6% (down from 1.2% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Annuncio • Mar 02
TCM Corporation Public Company Limited, Annual General Meeting, Apr 26, 2024 TCM Corporation Public Company Limited, Annual General Meeting, Apr 26, 2024, at 10:00 SE Asia Standard Time. Agenda: To consider to acknowledge the minutes of the 2023 Annual General Meeting of Shareholders; to acknowledge the report on the Company's operating results for the year 2023 and the Annual Report; to consider and approve the audited statement of financial position and statements of comprehensive income for the fiscal year ended 31 December 2023; to consider and approve the appropriation of profit from the operating result of the fiscal year 2023 and the non-payment of dividends to shareholders; to consider and approve bonus payments for the year 2023 to the Board of Directors; and to approve such other business. Reported Earnings • Nov 16
Third quarter 2023 earnings released: EPS: ฿0.005 (vs ฿0.022 in 3Q 2022) Third quarter 2023 results: EPS: ฿0.005 (down from ฿0.022 in 3Q 2022). Revenue: ฿1.85b (down 9.2% from 3Q 2022). Net income: ฿3.87m (down 77% from 3Q 2022). Profit margin: 0.2% (down from 0.8% in 3Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Buying Opportunity • Sep 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 12%. The fair value is estimated to be ฿2.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.9% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Aug 11
Second quarter 2023 earnings released: EPS: ฿0.012 (vs ฿0.008 loss in 2Q 2022) Second quarter 2023 results: EPS: ฿0.012 (up from ฿0.008 loss in 2Q 2022). Revenue: ฿2.15b (down 10.0% from 2Q 2022). Net income: ฿9.27m (up ฿15.5m from 2Q 2022). Profit margin: 0.4% (up from net loss in 2Q 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Aug 08
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 10%. The fair value is estimated to be ฿2.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years. Meanwhile, the company has become profitable. Buying Opportunity • Jul 20
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 11%. The fair value is estimated to be ฿2.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years. Meanwhile, the company has become profitable. Buying Opportunity • Jun 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 2.2%. The fair value is estimated to be ฿2.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • May 15
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ฿1.76, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 26x in the Consumer Durables industry in Thailand. Total returns to shareholders of 105% over the past three years. Buying Opportunity • May 11
Now 25% undervalued Over the last 90 days, the stock is up 2.3%. The fair value is estimated to be ฿2.41, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.1% over the last 3 years, while earnings per share has been flat. Buying Opportunity • Apr 25
Now 21% undervalued Over the last 90 days, the stock is up 4.9%. The fair value is estimated to be ฿2.41, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.1% over the last 3 years, while earnings per share has been flat. Buying Opportunity • Apr 05
Now 21% undervalued Over the last 90 days, the stock is up 9.8%. The fair value is estimated to be ฿2.41, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.1% over the last 3 years, while earnings per share has been flat. Valuation Update With 7 Day Price Move • Mar 14
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ฿1.73, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 26x in the Consumer Durables industry in Thailand. Total returns to shareholders of 116% over the past three years. Buying Opportunity • Mar 13
Now 24% undervalued Over the last 90 days, the stock is up 13%. The fair value is estimated to be ฿2.41, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.1% over the last 3 years, while earnings per share has been flat. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 6 highly experienced directors. 4 independent directors (5 non-independent directors). Independent Director Duangjai Lorlertwit was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Aug 14
Second quarter 2022 earnings released: ฿0.008 loss per share (vs ฿0.065 loss in 2Q 2021) Second quarter 2022 results: ฿0.008 loss per share (up from ฿0.065 loss in 2Q 2021). Revenue: ฿2.39b (up 36% from 2Q 2021). Net loss: ฿6.23m (loss narrowed 88% from 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance. Reported Earnings • May 19
First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind First quarter 2022 results: EPS: ฿0.025 (up from ฿0.045 loss in 1Q 2021). Revenue: ฿2.44b (up 32% from 1Q 2021). Net income: ฿19.2m (up ฿53.3m from 1Q 2021). Profit margin: 0.8% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Revenue missed analyst estimates by 6.0%. Earnings per share (EPS) exceeded analyst estimates by 33%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 6 highly experienced directors. 4 independent directors (5 non-independent directors). Independent Director Duangjai Lorlertwit was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Mar 02
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2021 results: ฿0.20 loss per share (down from ฿0.054 loss in FY 2020). Revenue: ฿7.82b (up 14% from FY 2020). Net loss: ฿152.8m (loss widened 273% from FY 2020). Revenue missed analyst estimates by 6.0%. Earnings per share (EPS) were also behind analyst expectations. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance. Reported Earnings • Nov 17
Third quarter 2021 earnings released: ฿0.012 loss per share (vs ฿0.11 profit in 3Q 2020) The company reported a soft third quarter result with weaker earnings and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: ฿2.04b (up 6.2% from 3Q 2020). Net loss: ฿9.19m (down 111% from profit in 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 103 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 18
Second quarter 2021 earnings released: ฿0.065 loss per share (vs ฿0.06 loss in 2Q 2020) The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: ฿1.76b (up 64% from 2Q 2020). Net loss: ฿49.9m (loss widened 9.1% from 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. Reported Earnings • May 18
First quarter 2021 earnings released: ฿0.045 loss per share (vs ฿0.06 loss in 1Q 2020) The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: ฿1.84b (up 17% from 1Q 2020). Net loss: ฿34.1m (loss narrowed 26% from 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance. Reported Earnings • Mar 02
Full year 2020 earnings released: ฿0.054 loss per share (vs ฿0.011 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: ฿6.87b (down 24% from FY 2019). Net loss: ฿41.0m (loss widened 371% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 74% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ฿1.59, the stock is trading at a trailing P/E ratio of 20.7x, down from the previous P/E ratio of 26.6x. This compares to an average P/E of 16x in the Consumer Durables industry in Thailand. Total return to shareholders over the past three years is a loss of 52%. Valuation Update With 7 Day Price Move • Feb 04
Investor sentiment improved over the past week After last week's 16% share price gain to ฿2.20, the stock is trading at a trailing P/E ratio of 28.7x, up from the previous P/E ratio of 24.7x. This compares to an average P/E of 27x in the Consumer Durables industry in Thailand. Total return to shareholders over the past three years is a loss of 34%. Is New 90 Day High Low • Jan 12
New 90-day high: ฿1.96 The company is up 62% from its price of ฿1.21 on 14 October 2020. The Thai market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Durables industry, which is up 9.0% over the same period. Valuation Update With 7 Day Price Move • Jan 12
Investor sentiment improved over the past week After last week's 15% share price gain to ฿1.96, the stock is trading at a trailing P/E ratio of 25.5x, up from the previous P/E ratio of 22.1x. This compares to an average P/E of 23x in the Consumer Durables industry in Thailand. Total return to shareholders over the past three years is a loss of 46%. Is New 90 Day High Low • Nov 16
New 90-day high: ฿1.25 The company is up 19% from its price of ฿1.05 on 18 August 2020. The Thai market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Durables industry, which is up 2.0% over the same period. 
